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Abstract
Low birth weight in humans is predictive of hypertension in
adultlife.Althoughthemechanismsunderlyingthislinkremain
unknown, fetal overexposure to glucocorticoids has been
implicated.Wepreviouslyshowedthatprenataldexamethasone
(DEX)exposureintheratlowersbirthweightandprogrammes
adult hypertension. The current study aimed to further
investigate the nature of this hypertension and to elucidate its
origins. Unlike previous studies, we assessed offspring blood
pressure (BP) with radiotelemetry, which is unaffected by
stress artefacts of measurement. We show that prenatal DEX
duringthelastweekofpregnancyresultsinoffspringoflowbirth
weight (14% reduction) that have lower basal BP in adulthood
(w4–8 mmHg lower); with the commonly expected hyper-
tensive phenotype only being noted when these offspring are
subjected toevenmilddisturbance ora moresevere stressor(up
to 30 mmHg higher than controls). Moreover, DEX-treated
offspring sustain their stress-induced hypertension for longer.
Promotion of systemic catecholamine release (amphetamine)
induced a signiﬁcantly greater rise of BP in the DEX animals
(77% increase) over that observed in the vehicle controls.
Additionally, we demonstrate that the isolated mesenteric
vasculature of DEX-treated offspring display greater sensitivity
to noradrenaline and other vasoconstrictors. We therefore
conclude that altered sympathetic responses mediate the stress-
induced hypertension associated with prenatal DEX
programming.
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Introduction
Much evidence suggests that transient adversity in the prenatal
environmentexertspermanenteffectsonsubsequentphysiology
and increases disease risk in adult life (Curhan et al.1 9 9 6 b, Fall
et al.1 9 9 8 , Law et al.2 0 0 1 , Seckl 2004). A plethora of
epidemiological studies have shown that low birth weight, a
proposed surrogate for intrauterine adversity, is associated with
hypertension (Barker 1990), type 2 diabetes (McCance et al.
1994), the metabolic syndrome and deaths from ischemic heart
diseaseinlaterlife(Curhanetal.1996a,Barker1999).Toexplain
these links, the concept of developmental ‘programming’ has
been advanced, whereby a factor acting during a critical
developmental window affects the ontogeny of speciﬁcally
vulnerable cell targets, permanently altering tissue structure
and/or function and hence the eventual risk of disease
(Benediktsson et al.1 9 9 3 , Barker 2003, Seckl 2004). However,
such environmentally determined developmental effects are
widespread in the animal kingdom and often associate with
phenotypeswhichappeartorepresentaﬁnelybalancedtransient
advantage in a particular environment. Such developmental
‘trade-offs’ can become disadvantageous late in the lifespan.
Fetal ‘programming’ may be investigated in a controlled
manner using laboratory animals that age relatively rapidly and
have similar or identical genetic backgrounds. In rats and many
other mammalian species, fetal exposure to excess glucocorti-
coids via maternal stress, inhibition of placental 11b-hydroxy-
steroid dehydrogenase type 2, the normal ‘barrier’to maternal
glucocorticoids, or its bypass with non-substrate synthetic
glucocorticoids, such as dexamethasone (DEX), commonly
used in obstetric practice, all lower birth weight. The adult
offspring show permanently elevated glucose and insulin levels
andhypertension(Levittet al.19 96 ,Nyirendaetal.19 98 ,2001,
Langdown et al. 2001, Sugden et al. 2001). Although
programmed increases in the expression of key hepatic
gluconeogenic enzymes may later underpin hyperglycaemia
(Nyirenda et al.1 9 9 8 , 2001), little is known of the mechanisms
by which glucocorticoids ‘programme’ higher blood pressure
(BP) or whether this phenotype carries any advantage.
Prenatal DEX, speciﬁcally in the last trimester, affects the
development and maturation of speciﬁc organs related to BP
control and maintenance; notably the developing heart,
kidney, vasculature and brain (Torres et al. 1997, Ortiz et al.
2003, Kreider et al. 2005, Roghair et al. 2005). Alterations in
the activity or responsivity of the sympathetic nervous system
(SNS), either systemically or in one of these speciﬁc regions,
could provide a potential explanation for the manner in
which prenatal glucocorticoids promote adulthood hyper-
tension. Indeed, in humans, increased SNS activity has long
been proposed as a mechanism to explain the pathogenesis of
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Saruta 1996). Consistent with this hypothesis, elevated SNS
activity, established in utero, links small size at birth with raised
BP in adult life (Phillips & Barker 1997). In rats, prenatal
DEX alters the development of cardiac and central
sympathetic innervation and activity (Slotkin et al. 1992,
Bian et al. 1993). Permanent changes in the pattern and
expression of adrenergic receptors (Huff et al. 1991, Bian et al.
1992) have the potential to alter vascular responsivity to
vasoconstrictors. Similar ﬁndings have been reported with
DEX administration during pregnancy in sheep (Stein et al.
1994, Padbury et al. 1995, Tseng et al. 1995).
To study more closely diurnal variation and the role of the
SNS in adult BP in animals prenatally treated with excess
glucocorticoids, we used the DEX-exposed rat model. Radio-
telemetry (Anderson et al.1 9 9 9 ) enabled the remote recording
ofBPinconscious, unrestrainedratswithminimalstresseffects.
Materials and Methods
Animals
Adult Wistar rats (200–250 g; Harlan UK Ltd, Bichester, UK)
were maintained under conditions of controlled lighting
(lights on 0700–1900 h) and temperature (22 8C) with ad
libitum access to food (standard rat chow) and water. All
experiments were performed according to the UK Animals
(Scientiﬁc Procedures) Act, 1986.
Prenatal treatments
Virgin female rats were housed with male rats. Pregnancy was
conﬁrmed by the presence of a vaginal plug, checked every
morning. Pregnant females were housed singly, and randomly
assigned to one of two treatment groups (nZ9–10 per group).
DEX(100 mg/kgperday,dissolvedin4%ethanolin0.9%saline,
200 mg/ml;Sigma–Aldrich)wasinjected(subcutaneously)daily
(0900 h) on embryonic days 15–21 inclusive (Nyirenda et al.
1998); control animals received vehicle (VEH) injections.
Litters
Onthedayofbirth(postnatalday1),litterswereweighed,sexed
and culled to eight pups per litter, retaining equal numbers of
male and female pups where possible. Litters were then left
undisturbed till weaning (postnatal day 21), apart from routine
weeklymaintenance.Afterweaning,maleandfemalepupsfrom
each litter were housed in single sex groups of two to four. All
ratsunderwentaminimumof2weeksofdailyhandlingpriorto
being utilised in experiments. Females were tested during
oestrus, conﬁrmed by vaginal cytology. Epithelial cells were
aspirated from the vagina with 1 ml saline and placed on a glass
slide for microscopic inspection. The oestrous cycle was then
staged according to the Journal of Animal Technicians Association,
12, No. 1. Staging was independently veriﬁed by at least one
other researcher/animal technician.
Radiotelemetry monitoring of offspring BP, heart rate and activity
BP(systolicBP,SBP;diastolicBP,DBP;meanarterialpressure,
MAP and pulse pressure, PP), heart rate (HR), and activity
were assessed by radiotelemetry (Dataquest IV, Data Sciences
International, St Paul, MN, USA; Anderson et al. 1999).
Randomly selected littermates (ﬁve males and ﬁve females,
from eight vehicle and eight DEX litters) at 7–8 months were
anaesthetised with halothane. A ﬂexible catheter was secured
in the abdominal aorta, and the telemetry transmitter was
sutured to the abdominal wall. On recovery, rats were housed
in individual cages, and each cage was placed over a receiver
panel with output to a PC. Each cage and its receiver panel
were housed in a specially designed steel cage rack, to prevent
radio signal disturbance from neighbouring animals, and the
rack was stored in a quiet room. After a 10-day recovery
period, haemodynamic measurements were recorded for 10 s
every 30 min (Khan et al. 2003).
Induction of stress by disturbance, weighing and restraint procedure
Offspringweresubjectedtoaseriesofgradedstressors:i)simple
disturbance(aresearcherenteringtheirroom);ii)beingweighed
andiii)restraintinaPerspexcylinderfor15 min.Toevaluatethe
stressresponsetoweighing,haemodynamicmeasurementswere
recorded prior toandimmediatelyafter removalofthe rat from
itscageandagainat5-minpost-weighing,whentheanimalwas
replaced. For the restraint procedure, measurements were
collected prior to the rat being placed in the cylinder,
throughout the 15-min restraint period, and at 15-min post-
restraint, on being returned to its cage. A rest period of 2 days
was allowed between experiments.
Haemodynamic responses to alterations in catecholaminergic
mechanisms
Haemodynamic responses were collected for 15 min
following a low dose of i.p. D-amphetamine (0.5 mg/kg), to
cause systemic catecholamine release.
Vascular responses to noradrenaline, vasopressin and potassium
chloride
Pairs of rats (one VEH and one DEX) were anaesthetised with
sodium pentobarbitone, and the mesenteric vasculature was
catheterised and perfused with Krebs bicarbonate Ringer’s
solution, and isolated as previously described (McGregor
1965). Perfusion pressure with constant ﬂow rate was
measured continuously via an Elcomatic EM 720 transducer,
and recorded on a MacLab Chart V3.3.5 program (ADI,
Oxford, UK). On alternate days, mesenteric preparations
from each treatment group were attached to alternate
transducers, to exclude the possibility of any positional
artefact. Following a 15-min equilibration period, a brief
‘wake-up’ bolus of 20 mM noradrenaline (NA; Sigma–
Aldrich) was administered (Hadoke et al. 2006).
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both male and female offspring were tested simultaneously for
periods of 3 min with increasing concentrations of agonists in
the following order: NA (0.1–20 mM), vasopressin (AVP;
0.5–20 nM; Sigma–Aldrich) and potassium chloride (KCl;
25–125 mM), all agonists were prepared in Ringer’s solution.
Between tests, the vasculatures were infused with Ringer’s
solution alone, during which time the perfusion pressure
returned to basal values. A recovery period of at least 30 min
was allowed between each agonist.
Statistical analyses
BP, HR and activity Basal BP parameters (SBP, DBP,
MAP, PP and HR) and activities for each prenatal treatment
(VEH or DEX) and gender, are shown in Table 2A (meansG
S.D). Data are calculated for each rat as an average over 3 days
of telemetry recording. Statistical analysis of the data was by
multivariate repeated measures MANOVA (with prenatal
treatment, gender and light/dark period as dependent
variables, and rat identiﬁcation number/representative of
each litter and time of day as random variables) which was
carried out on the raw BP data for each rat and signiﬁcance
values for each dependent variable, together with interactions
between variables are shown in Table 2.
Values following drug treatment (amphetamine) were
analysed by three-way ANOVA with prenatal treatment,
amphetamine treatment and gender as variables, followed by
Dunnett’s post hoc test. Statistical signiﬁcance was assumed at a
value of P!0.05.
Vascular studies All data are meanGS.E.M. For each
mesenteric preparation, the maximal response and the
concentration of agonist required for a 50% response (EC50)
were determined. Differences in the mean log EC50 and
maximal response values between VEH- and DEX-treated
offspring mesenteric vasculatures were compared using
Student’s unpaired t-test. Data were further analysed by
two-way ANOVA (prenatal treatment!dose of agonist);
results were considered signiﬁcant when P!0.05.
Results
Gestational weight gain, birth phenotype and catch-up growth
DEX administration throughout the ﬁnal week of gestation
resulted in a signiﬁcant reduction in maternal weight gain,
with no differences noted in the length of gestation, litter size,
ratio of male to female pups born or pup viability (Table 1).
Consistent with previous studies, DEX caused a signiﬁcant
reduction in the birth weight of offspring, which was
observed to the same degree in both male and female pups
(O’Regan et al. 2004). By weaning (postnatal day 21) and
throughout adult life, the body weights of male and female
offspring, treated with VEH or DEX were similar, that is, full
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apparently altered by prenatal glucocorticoid treatment in
either males (VEH: 0.005G0.0002 g/g bwt, nZ7 and DEX:
0.0051G0.00014 g/g bwt, nZ5) or females (VEH:
0.00535G0.00011 g/g bwt, nZ5 and DEX: 0.00495G
0.000177 g/g !0.001 bwt, nZ6).
Radiotelemetric monitoring of offspring BP, HR and activity
under basal conditions
BP, HR and activity showed the expected sex variations and
circadian variation in male and female offspring of both the
prenatal treatment groups with the highest BP (MAP, SBP
and DBP), HR and activity levels in the dark phase and lowest
values during the light phase (Table 2 and Figs 1 and 2).
Contrary to previous reports using indirect (tail cuff) and
direct but stressful (carotid cannulation) methods to assess BP,
both male and female DEX offspring showed basal
hypotension with lower SBP, DBP, PP and HR compared
with VEH rats (Figs 1 and 2 and Table 2), which was not
dependent on whether the measurements were taken in the
active, dark phase or the quiescent, light phase. However,
there was a signiﬁcant interaction between BP parameters and
gender (Table 2), greater effects of prenatal treatment (PNT)
being apparent in the males.
It was also observed that the DEX rats were less active than
the VEH controls (Table 2), this effect was greater in the
females compared with the males (interaction of PNT and
gender, P!0.001) and was observed mostly in the active,
dark phase of the 24 h (interaction of PNT and day/night
phase, P!0.001). The reduced activity of the DEX rats may
contribute to the observed hypotension.
Table 2 (A) Blood pressure parameters measured under basal conditions in adult offspring of VEH- and dexamethasone (DEX)-treated dams.
(B) Table of P values resulting from MANOVA of telemetry data in A. Dependent variables are prenatal treatment (VEH or DEX), gender and
day or night measurements. Results are meanGS.D. (number of observations), from all data collected over 72-h period for each rat
(A) Telemetry data
VEH _ DEX _ VEH \ DEX \
Systolic (mmHg)
Av daily BP 144.5G10.6 (750) 140.2G15.2 (717) 138.3G10.4 (450) 129.7G12.7 (749)
Av BP in light phase 141.7G9.5 (390) 138.3G16.2 (386) 135.2G10.2 (234) 126.6G11.8 (390)
Av BP in dark phase 147.6G11.0 (360) 142.5G13.7 (331) 141.6G9.5 (216) 133.1G12.8 (359)
Diastolic (mmHg)
Av daily BP 106.1G9.8 (750) 103.3G12.8 (717) 101.5G8.9 (450) 99.4G13.0 (749)
Av BP in light phase 103.4G8.6 (390) 101.6G13.4 (386) 99.4G8.4 (234) 96.3G12.0 (390)
Av BP in dark phase 109.0G10.2 (360) 105.3G11.4 (331) 103.8G8.9 (216) 102.7G13.3 (360)
MAP (mmHg)
Av daily BP 118.9G10.6 (750) 115.6G15.5 (717) 113.8G9.2 (450) 109.4G4.7 (749)
Av BP in light phase 116.1G8.7 (390) 113.9G14.4 (386) 111.3G8.9 (234) 106.4G11.7 (390)
Av BP in dark phase 121.9G10.3 (360) 117.7G12.1 (331) 116.4G8.9 (216) 112.7G12.9 (359)
Pulse pressure (mmHg)
Av daily PP 38.5G3.9 (750) 36.9G3.7 (717) 36.8G4.0 (450) 30.4G5.9 (749)
Av PP in light phase 38.3G3.7 (390) 36.7G3.8 (386) 35.8G3.8 (234) 30.3G5.1 (390)
Av PP in dark phase 38.7G4.2 (360) 37.2G3.6 (331) 37.8G4.08 (216) 30.4G5.9 (359)
Heart Rate (beats/min)
Av daily HR 339.3G60.4 (750) 349.2G62.3 (717) 366.9G64.2 (450) 366.0G62.2 (750)
Av HR in light phase 306.7G44.1 (390) 323.1G53.3 (386) 335.7G54.8 (234) 332.1G48.4 (390)
Av HR in dark phase 374.6G55.7 (360) 379.6G58.4 (331) 400.7G56.0 (216) 398.7G56.5 (359)
Activity (arbitrary units)
Av daily activity 2.88G2.81 (745) 2.51G2.50 (745) 4.85G4.38 (447) 3.50G3.74 (750)
Av activity in light phase 1.41G1.73 (385) 1.29G1.58 (385) 2.53G2.90 (231) 1.70G2.25 (385)
Av activity in dark phase 4.46G2.88 (360) 3.82G2.64 (360) 7.32G4.34 (216) 5.42G4.05 (360)
(B) P values resulting from MANOVA of telemetry data
PNT Day/night Gender Interaction PNT!gender Interaction PNT!day/night phase
Parameter
SBP 0.001 0.001 0.001 0.003 0.467
DBP 0.001 0.001 0.001 0.008 0.847
MAP 0.001 0.001 0.001 0.489 0.894
PP 0.001 0.001 0.001 0.001 0.017
HR 0.038 0.001 0.001 0.002 0.236
Activity 0.001 0.001 0.001 0.001 0.001
Bold numbers indicate signiﬁcance (P!0.05) of dependent variables and interactions of these variables. SBP, systolic blood pressure; DBP, diastolic blood
pressure; MAP, mean arterial pressure; PP, pulse pressure; HR, heart rate.
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In utero exposure to DEX has been shown to cause a lifelong
elevation in basal BP when measured by tail-cuff plethysmo-
graphy and carotid cannulation. An exaggerated stress
response to these measurement techniques could account
for apparent hypertension. As shown in Fig. 3 (A, B and E),
male, prenatal DEX-treated offspring were exquisitely
sensitive to stress, displaying graded hypertensive responses
when disturbed bya researcherentering their room and when
restrained. Even weighing elicited a hypersensitive responsein
DEX-treated offspring (change in SBP; VEH 10G2 mmHg
and DEX 19G3 mmHg; P!0.05). Moreover, DEX-treated
offspring start with a reduced MAP compared with vehicle
controls (Fig. 3A and B) and maintain their stress-induced
hypertension for longer once released from restraint (Fig. 3E),
and after weighing (change in SBP 5-min post-weighing;
VEH 7G5 mmHg and DEX 23G5 mmHg; P!0.05).
DEX-treated offspring further displayed signiﬁcantly greater
increases in HR in response toweighing (VEH 117G17 bpm
and DEX 156G25 bpm; P!0.05), and restraint (VEH
86G11 bpm and DEX 136G19 bpm; P!0.05). The greater
tachycardia on disturbance of prenatal DEX offspring was not
associated with changes in activity (weighing: VEH 5.2G1
AU, DEX 5G1 AU and restraint: VEH 4.8G1.2 AU, DEX
4.6G1.8 AU). Although there was a signiﬁcant response in
BP to stress in all females, there was no signiﬁcant difference
between the VEH- and DEX-treated offspring in response to
disturbance or restraint stress but the recovery period after
stress shows DEX females take longer to return basal levels of
MAP following restraint (Fig. 3C–E).
Prenatal DEX causes exaggerated hypertensive responses to
catecholaminergic stimulation
To assess the role of the SNS in mediating this stress-induced
hypertension,weadministeredalowdoseofD-amphetamine,to
inducecatecholaminerelease.WhiletheDEX-treatedoffspring
showedlowerbasalMAPspriortoamphetamineadministration
(Fig. 4A and B), they showed signiﬁcantly greater increases in
MAP and HR when treated with the drug compared with
controls (amphetamine treatment F(1,20)Z21.54, PZ0.0002;
prenatal treatment F(1,20)Z13.19, PZ0.0017; Fig. 4A–C).
Whenthedatawereseparatedintomaleandfemaleresponses,it
was demonstrated that there was no indication of a sex-speciﬁc
effect (F(1,20)Z0.52, PZ0.48; Fig. 4C).
Responsiveness of mesenteric vasculature to NA, AVP and KCL
To examine further the basis for increased responsivity to
catecholaminergic stimulation in DEX-exposed offspring,
resistance (mesenteric) vessels were perfused ex vivo
(Fig. 5A–C). Basal perfusion pressures were similar in the two
groups of rats. Infusion of all agonists caused a concentration-
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last week of gestation. Data are expressed as 6-h rolling averages
over 3 days for each treatment group. nZ4–5 per group.
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in both groups at 5 mMf o rN Aa n d1 0n Mf o rA V P .H o w e v e r ,
tissuesfromDEX-treatedmaleoffspringweresigniﬁcantlymore
responsive (the curves from DEX-treated offspring were
signiﬁcantly different from VEH controls; Fig. 5) and the Vmax
(indicativeofnumberofreceptors)washigherintheDEXgroup
in response to NA in both sexes (male VEH: 305G13 mmHg;
male DEX: 360G4m m H g ;PZ0.004; t-test. Female VEH:
292G5m m H g ;f e m a l eD E X :3 4 5 G7 mmHg; PZ0.001).
Female offspring
Several reports suggest that prenatal ‘programming’ pheno-
types are sexually dimorphic, so the perfusion studies were
repeated in females. Similar basal perfusion pressures were
noted in the two prenatal treatment groups. NA caused a
concentration-dependent increase in perfusion pressures,
with plateaux reached at 2 mM in both treatment groups
(Fig. 5D). However, the mesenteric vasculatures from DEX-
treatedoffspring weresigniﬁcantly moreresponsive to NA,(as
analysed by two-way ANOVA), even though the maximal
contraction (VEH 344G40 mmHg versus DEX 373G
30 mmHg; PZ0.16) and EC50 (vehicle 0.43G0.02 mM
versus DEX 0.39G0.03 mM; PZ0.16) values were similar
for both treatment groups. DEX treatment did not affect the
pattern of responses to either AVPor KCl. Maximal responses
in both groups were achieved at 5 nM AVP and 125 mM KCl
(data not shown).
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The striking novel ﬁnding of this study is that prenatal DEX
results in lower basal BP in the male and female adult
offspring; with the commonly expected hypertensive pheno-
type only being noted when these offspring are subjected to
a stressor, after which they exhibit a prolonged and excessive
hypertensive response. These exaggerated hypertensive
responses are mediated by alterations in the responsivity
of the SNS, being further exaggerated by promotion
of catecholamine release. Additionally, DEX-treated
offspring display greater sensitivity to catecholamines, and
only in males other vasoconstrictors, in resistance (mesen-
teric) vasculature.
Unexpectedly, over many days of recording undisturbed rats
in their home cages, prenatal DEX-exposed adult rats showed
lower BP than controls. This contrasts with both tail cuff
plethysmography and direct carotid cannulation data in this
model (Levitt et al.1 9 9 6 ) and in other models of ‘fetal
programming’ (Woodall et al.1 9 9 6 , Langley-Evans 1997,
Woods 2006) most of which have generally employed
techniques which involve stressful preheating of the tail and/
or physical restraint or short-term recovery from anaesthesia.
Indeed,severalstudieshavedocumentedbytelemetrythestress-
induced hypertension observed following restraint or using the
tail-cuff protocol (Gross & Luft 2003, Whitesall et al.2 0 0 4 ,
D’Angelo et al.2 0 0 5 , Kurtz et al.2 0 0 5 ), conﬁrming the
telemetry technique as the ‘gold standard’ for BP recording. In
our study,radiotelemetricmeasurementswererecorded1week
after implantation of intra-arterial cannulae to allow complete
recovery from established effects of surgery. Previous studies
have used telemetry to determine BP in other models of fetal
programming following maternal undernutrition (Tonkiss et al.
1998,Khanetal.20 03 ,Fernandez-Twinnetal.20 06 )orut erine
artery ligation (Jansson & Lambert 1999). BP differences by
telemetry have generally been slight, with normotension or at
most mild hypertension, compared with more overt hyperten-
sion using indirect techniques. The quite clear-cut lower basal
BP seen here in males and females in both active and quiescent
phases may therefore reﬂect speciﬁc effects of prenatal
glucocorticoid excess compared with other manipulations,
even though it is acknowledged that glucocorticoid program-
ming is combined with an effect on food intake and maternal
weight (present data; Levitt et al.1 9 9 6 , Welberg et al.2 0 0 1 ,
Woods 2006). However, short-term measurements of BP, even
over a few hours, failed to attribute statistical signiﬁcance
betweentheprenatallytreatedgroupsinthisstudy,emphasizing
the statistical power of the telemetric BP measurements,
but highlighting potential differences between studies and
analysis of the data.
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attributable to decreased activity in DEX rats compared with
VEH. However, activity differences are greater in the female
DEX rats (compared with female VEH rats), while BP
parameters of hypotension are greater in the male DEX rats
indicatingthatseveralparametersmaybealteredtomediatethe
BP changes and that these mechanisms may be sex speciﬁc.
Merelyenteringtheroominwhichtheratswerehousedwas
sufﬁcient to drive hypertension selectively in male, prenatal
DEX-exposed offspring. When further subjected to a
moderate stressor (weighing) and the more severe restraint
stress the hypertensive responses of the male DEX-treated
offspring were signiﬁcantly augmented, suggesting increased
sensitivity to environmental stress. An increased reactivity to
stressful environmental stimuli may lead to established
hypertension through frequent transient BP elevations
(Folkow et al. 1978). Whether or not the prenatal DEX-
exposed offspring will eventually become permanently
hypertensive warrants further study, as true life consists of a
constantseriesof‘stressfulsituations’thathavetobedealtwith,
and this is not mimicked in undisturbed laboratory animals.
Indeed,theDEX-treatedoffspringmaintainedtheirhyperten-
sion long after the removal of each stressor. Interestingly,
offspring of malnourished dams display a greater hypertensive
response to stress (ammonia odour) echoing the clear stress-
responsivehypertensionshownhereinprenatalglucocorticoid
programming (Tonkiss et al. 1998). It is therefore tempting to
speculate that prenatal glucocorticoid programming of
exaggerated cardiovascular responses to stress may be the
fundamental change in these models, with permanent
hypertension a secondary phenomenon dependent upon the
postnatal environment and its challenges. This would parallel
theemergingconceptsofampliﬁcationofthelowbirthweight
babymetabolicphenotypebypostnatalcaloricexcess(Ozanne
& Nicholas Hales 2005). Moreover, lower basal BP but
enhancedresponsestostressalignperhapsbetterwithconcepts
of adaptive advantages to the predicted (stressful) postnatal
environment of a stressed pregnancy than merely constant
hypertension, which has few apparent beneﬁts.
DEX-treatedoffspringhadhigherHRwithstress,amarker,
although indirect, of increased sympathetic drive. The
cardiodynamic responses to catecholamine release with
amphetamine (or catecholamine depletion with reserpine,
O’Reganunpublishedresults)stronglysupportthisnotionof a
more responsive SNS in DEX-programmed adult rats.
Amphetamine caused an exaggerated increase in BP in
DEX-treated offspring compared with controls and reserpine
abolished BP differences between DEX and VEH groups
basallyandinresponsetostress.TheSNSparticipatesinseveral
stress responses, even in fetal life (McMillen et al. 2001) and
thereforeprenatalexposuretovariousstressorsmightaffectthe
development of sympathetic innervation or its regulation.
Epidemiological evidence of HR variability in infants
demonstratesapositivecorrelationofthisindexofsympathetic
activity with low birth weight, suggesting that decreased fetal
growth is associated with a dysfunctional autonomic nervous
system which may play a role in programming of BP (Massin
et al.2 0 0 1 ). Indeed in rats, the offspring of prenatal
DEX-treated dams have increased NA turnover in central
brain regions concerned with BP control (Slotkin et al. 1992),
however, cardiac b-adrenergic responses are blunted in low
protein diet-induced-programmed rats (Fernandez-Twinn
etal.2006).Indistinctprenatalratmodels,gestationalnicotine
impairs the maturation of both central and peripheral
catecholaminergic pathways (Navarro et al. 1990) and hypoxia
alters development of sympathetic centres involved in BP
regulation (Peyronnet et al. 2002), effects which persist into
adulthood.Similarly,ligationoftheumbilicalarteryaltersSNS
activityinnewbornsheep(Oyamaetal.1992)andadultfemale
rat offspring (Jansson & Lambert 1999). Taken together, these
data indicate that diverse challenges in utero alter the
development and function of the adult SNS. A recent study
of low birth weight adult humans proposed that their lower
resting muscle sympathetic nerve activities were a function of
altered SNS development (Weitz et al. 2003).
Sex effects on BP regulation in prenatal-programming models
ha v ebeensho wninafe wstudies(Kindetal.2002,O’Reganetal.
2004),butnotothers(Langley-Evansetal.1996,Woods & Weeks
2005), although the hypertension may be generated by
sex-speciﬁc mechanisms (McMullen & Langley-Evans 2005a,b).
Indeed in humans, females have been shown to have more
efﬁcientregulationofSNSpathways,makingthemlesssusceptible
tohypertension(Hinojosa-Laborde et al. 1999). However, in this
study, we show similareffects on BP in males and females, but the
magnitude of hypotension and a greater stress-induced hyperten-
sion is observed in males. The response to catecholamine release
was similar in both sexes. Therefore, further studies will be
required to tease out the mechanisms underpinning the
sex-speciﬁc responsivity in this programming model.
Whatever the changes in SNS drive, DEX-treated off-
spring showed greater in vitro mesenteric pressor responses to
NA in both male and females suggesting increased tissue
sensitivity. There were also greater pressor responses to AVP
and a depolarizing potassium solution in males only. Similar
results were obtained in a study looking at female offspring
from mothers treated with DEX throughout pregnancy
(Hadoke et al. 2006). The in vitro perfusion preparation used
in these studies was separated from other in vivo systems (e.g.
circulating angiotensin II, endothelin), suggesting that a
change in receptor binding or alterations in the production of
local vasorelaxants/constrictors underlies the increased
vascular sensitivity. Glucocorticoids may regulate the
synthesis of vasoactive compounds, such as prostaglandins or
nitric oxide, which in turn modulate peripheral vascular
reactivity. Indeed, inhibition of nitric oxide synthesis
(Wallerath et al. 1999) and decreased levels of both
prostaglandin and its mediator adenylate cyclase (Handa
et al. 1984) have been demonstrated in rats with adult DEX-
induced hypertension. Similarly, increased mesenteric vascu-
lature sensitivity to NA has been observed in rats treated as
adults with low doses of DEX (Russo et al. 1990). Whether
the effects are due to the known modest elevations of
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Welberg et al. 2001) or reﬂect primary developmental effects
on the mesenteric vasculature that persist into adult life
remains uncertain. The gender differences in mesenteric
vasculature responses of DEX-treated offspring to both AVP
and KCl are intriguing, and could possibly reﬂect changes in
vascular reactivity during the reproductive cycle (Dalle Lucca
et al. 2000), and the effect of sex steroids on vascular smooth
muscle sensitivity (Garcia-Villalon et al. 1996). Interestingly,
gender has previously been demonstrated to have no effect on
the sensitivity to NA in both the rat tail artery and aorta (Li &
Duckles 1994, Fulton & Stallone 2002).
The present study provides novel and exciting information
regarding the nature and mechanisms of glucocorticoid-
induced alterations in postnatal BP. As the prenatal glucocorti-
coid exposure models extend our understanding of the fetal
originsphenomena,itisclear thatthereisaneedfor replication
and extended studies in humans. Only then, will we be better
equipped to understand both the immediate and long-term
consequences of antenatal glucocorticoid treatment.
Acknowledgements
Expert animal assistance was provided by Gillian Brooker for
the surgical implantation of telemetric devices, and by Willy
Mungall. This study was supported by a Wellcome Trust
CVRI studentship (D O’R), the Wellcome Trust (J R S and
M C H) and the Medical Research Council (C J K). The
authors declare that there is no conﬂict of interest that would
prejudice the impartiality of this scientiﬁc work.
References
Anderson NH, Devlin AM, Graham D, Morton JJ, Hamilton CA, Reid JL,
Schork NJ & Dominiczak AF 1999 Telemetry for cardiovascular
monitoring in a pharmacological study: new approaches to data analysis.
Hypertension 33 248–255.
Barker DJ 1990 The fetal and infant origins of adult disease. British Medical
Journal 301 1111.
Barker DJ 1999 Fetal origins of cardiovascular disease. Annals of Medicine
31(Suppl 1) 3–6.
Barker DJ 2003 The developmental origins of adult disease. European Journal of
Epidemiology 18 733–736.
Benediktsson R, Lindsay RS, Noble J, Seckl JR & Edwards CR 1993
Glucocorticoid exposure in utero: new model for adult hypertension.
Lancet 341 339–341.
Bian XP, Seidler FJ& Slotkin TA 1992 Promotional role for glucocorticoids in
the development of intracellular signalling: enhanced cardiac and renal
adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli
after low-dose fetal dexamethasone exposure. Journal of Developmental
Physiology 17 289–297.
Bian X, Seidler FJ & Slotkin TA 1993 Fetal dexamethasone exposure
interferes with establishment of cardiac noradrenergic innervation and
sympathetic activity. Teratology 47 109–117.
Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL & Stampfer
MJ 1996a Birth weight and adult hypertension, diabetes mellitus, and
obesity in US men. Circulation 94 3246–3250.
Curhan GC, Chertow GM, Willett WC, Spiegelman D, Colditz GA, Manson
JE, Speizer FE & Stampfer MJ 1996b Birth weight and adult hypertension
and obesity in women. Circulation 94 1310–1315.
Dalle Lucca JJ, Adeagbo AS & Alsip NL 2000 Inﬂuence of oestrous cycle and
pregnancy on the reactivity of the rat mesenteric vascular bed. Human
Reproduction 15 961–968.
D’Angelo G, Elmarakby AA, Pollock DM & Stepp DW 2005 Fructose
feeding increases insulin resistance but not blood pressure in Sprague–
Dawley rats. Hypertension 46 806–811.
Fall CH, Stein CE, Kumaran K, Cox V, Osmond C, Barker DJ & Hales CN
1998 Size at birth, maternal weight, and type 2 diabetes in South India.
Diabetic Medicine 15 220–227.
Fernandez-Twinn DS, Ekizoglou S, Wayman A, Petry CJ & Ozanne SE 2006
Maternal low protein diet programs cardiac beta-adrenergic response and
signalling in 3 month old male offspring. American Journal of Physiology 291
R429–R436.
Folkow B, Hallback MIL, Genest J, Koiw E & Kuchel O 1978
Physiopathology of spontaneous hypertension in rats. In Hypertension:
Pathophysiology and Treatment, pp 507–529. Eds J Genest, E Koiw &
O Kuchel. New York: MacGraw Hill.
Fulton CT & Stallone JN 2002 Sexual dimorphism in prostanoid-
potentiated vascular contraction: roles of endothelium and ovarian
steroids. American Journal of Physiology 283 H2062–H2073.
Garcia-Villalon AL, Buchholz JN, Krause DN & Duckles SP 1996 Sex
differences in the effects of 17 beta-estradiol on vascular adrenergic
responses. European Journal of Pharmacology 314 339–345.
Gross V & Luft FC 2003 Exercising restraint in measuring blood pressure in
conscious mice. Hypertension 41 879–881.
Hadoke PW, Lindsay RS, Seckl JR, Walker BR & Kenyon CJ 2006
Altered vascular contractility in adult female rats with hypertension
programmed by prenatal glucocorticoid exposure. Journal of Endocrinology
188 435–442.
Handa M, Kondo K, Suzuki H & Saruta T 1984 Dexamethasone
hypertension in rats: role of prostaglandins and pressor sensitivity to
norepinephrine. Hypertension 6 236–241.
Hinojosa-Laborde C, Chapa I, Lange D & Haywood JR 1999 Gender
differences in sympathetic nervous system regulation. Clinical and
Experimental Pharmacology and Physiology 26 122–126.
Huff RA, Seidler FJ & Slotkin TA 1991 Glucocorticoids regulate the
ontogenetic transition of adrenergic receptor subtypes in rat liver. Life
Sciences 48 1059–1065.
Jansson T & Lambert GW 1999 Effect of intrauterine growth restriction on
blood pressure, glucose tolerance and sympathetic nervous system activity
in the rat at 3–4 months of age. Journal of Hypertension 17 1239–1248.
Khan IY, Taylor PD, Dekou V, Seed PT, Lakasing L, Graham D, Dominiczak
AF, Hanson MA & Poston L 2003 Gender-linked hypertension in offspring
of lard-fed pregnant rats. Hypertension 41 168–175.
Kind KL, Simonetta G, Clifton PM, Robinson JS & Owens JA 2002 Effect of
maternal feed restriction on blood pressure in the adult guinea pig.
Experimental Physiology 87 469–477.
Kreider ML, Aldridge JE, Cousins MM, Oliver CA, Seidler FJ & Slotkin TA
2005 Disruption of rat forebrain development by glucocorticoids: critical
perinatal periods for effects on neural cell acquisition and on cell signaling
cascades mediating noradrenergic and cholinergic neurotransmitter/neuro-
trophic responses. Neuropsychopharmacology 30 1841–1855.
Kurtz TW, Grifﬁn KA, Bidani AK, Davisson RL & Hall JE 2005
Recommendations for blood pressure measurement in humans and
experimental animals: part 2: blood pressure measurement in experimental
animals: a statement for professionals from the Subcommittee of
Professional and Public Education of the American Heart Association
Council on High Blood Pressure Research. Arteriosclerosis, Thrombosis, and
Vascular Biology 25 E22–E33.
Langdown ML, Smith ND, Sugden MC & Holness MJ 2001 Excessive
glucocorticoid exposure during late intrauterine development modulates
the expression of cardiac uncoupling proteins in adult hypertensive male
offspring. Pﬂugers Archiv 442 248–255.
Prenatal programming of hypertension . DO ’REGAN and others 351
www.endocrinology-journals.org Journal of Endocrinology (2008) 196, 343–352Langley-Evans SC 1997 Hypertension induced by foetal exposure to a maternal
low-protein diet, in the rat, is prevented by pharmacological blockade of
maternal glucocorticoid synthesis. Journal of Hypertension 15 537–544.
Langley-Evans SC, Phillips GJ, Benediktsson R, Gardner DS, Edwards CR,
Jackson AA & Seckl JR 1996 Protein intake in pregnancy, placental
glucocorticoid metabolism and the programming of hypertension in the rat.
Placenta 17 169–172.
Law CM, Egger P, Dada O, Delgado H, Kylberg E, Lavin P, Tang GH, von
Hertzen H, Shiell AW & Barker DJ 2001 Body size at birth and blood
pressure among children in developing countries. International Journal of
Epidemiology 30 52–57.
Levitt NS, Lindsay RS, Holmes MC & Seckl JR 1996 Dexamethasone in the
last week of pregnancy attenuates hippocampal glucocorticoid receptor
gene expression and elevates blood pressure in the adult offspring in the rat.
Neuroendocrinology 64 412–418.
Li Z & Duckles SP 1994 Inﬂuence of gender on vascular reactivity in the rat.
Journal of Pharmacology and Experimental Therapeutics 268 1426–1431.
Massin MM, Withofs N, Maeyns K & Ravet F 2001 The inﬂuence offetal and
postnatal growth on heart rate variability in young infants. Cardiology 95
80–83.
McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC & Bennett
PH 1994 Birth weight and non-insulin dependent diabetes: thrifty
genotype, thrifty phenotype, or surviving small baby genotype? British
Medical Journal 308 942–945.
McGregor DD 1965 The effect of sympathetic nerve stimulation on
vasoconstrictor responses in perfused mesenteric blood vessel of the rat.
Journal of Physiology 177 21–30.
McMillen IC, Adams MB, Ross JT, Coulter CL, Simonetta G, Owens JA,
Robinson JS & Edwards LJ 2001 Fetal growth restriction: adaptations and
consequences. Reproduction 122 195–204.
McMullen S & Langley-Evans SC 2005a Maternal low-protein diet in rat
pregnancy programs blood pressure through sex-speciﬁc mechanisms.
American Journal of Physiology 288 R85–R90.
McMullen S & Langley-Evans SC 2005b Sex-speciﬁc effects of prenatal low-
protein and carbenoxolone exposure on renal angiotensin receptor
expression in rats. Hypertension 46 1374–1380.
Navarro HA, Mills E, Seidler FJ, Baker FE, Lappi SE, Tayyeb MI, Spencer JR
& Slotkin TA 1990 Prenatal nicotine exposure impairs beta-adrenergic
function: persistent chronotropic subsensitivity despite recovery from
deﬁcits in receptor binding. Brain Research Bulletin 25 233–237.
Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A & Seckl JR 1998
Glucocorticoid exposure in late gestation permanently programs rat hepatic
phosphoenolpyruvate carboxykinase and glucocorticoid receptor
expression and causes glucose intolerance in adult offspring. Journal of
Clinical Investigation 101 2174–2181.
Nyirenda MJ, Welberg LA & Seckl JR 2001 Programming hyperglycaemia in
the rat through prenatal exposure to glucocorticoids-fetal effect or maternal
inﬂuence? Journal of Endocrinology 170 653–660.
O’Regan D, Kenyon CJ, Seckl JR & Holmes MC 2004 Glucocorticoid
exposure in late gestation in the rat permanently programs gender-speciﬁc
differences in adult cardiovascular and metabolic physiology. American
Journal of Physiology 287 E863–E870.
Ortiz LA, Quan A, Zarzar F, Weinberg A & Baum M 2003 Prenatal
dexamethasone programs hypertension and renal injury in the rat.
Hypertension 41 328–334.
Oyama K, Padbury J, Martinez A, Chappell B, Stein H & Humme J 1992
Effects of fetal growth retardation on the development of central and
peripheral catecholaminergic pathways in the sheep. Journal of Developmental
Physiology 18 217–222.
Ozanne SE & Nicholas Hales C 2005 Poor fetal growth followed by rapid
postnatal catch-up growth leads to premature death. Mechanisms of Ageing
and Development 126 852–854.
Padbury JF, Polk DH, Ervin MG, Berry LM, Ikegami M & Jobe AH 1995
Postnatal cardiovascular and metabolic responses to a single intramuscular
dose of betamethasone in fetal sheep born prematurely by cesarean section.
Pediatric Research 38 709–715.
Peyronnet J, Dalmaz Y, Ehrstrom M, Mamet J, Roux JC, Pequignot JM,
Thoren HP & Lagercrantz H 2002 Long-lasting adverse effects of prenatal
hypoxia on developing autonomic nervous system and cardiovascular
parameters in rats. Pﬂugers Archiv 443 858–865.
Phillips DI & Barker DJ 1997 Association between low birthweight and high
resting pulse in adult life: is the sympathetic nervous system involved in
programming the insulin resistance syndrome? Diabetic Medicine 14 673–677.
Roghair RD, Lamb FS, Miller FJ, Jr, Scholz TD & Segar JL 2005 Early
gestation dexamethasone programs enhanced postnatal ovine coronary
artery vascular reactivity. American Journal of Physiology 288 R46–R53.
Russo D, Fraser R & Kenyon CJ 1990 Increased sensitivity to noradrenaline in
glucocorticoid-treated rats: the effects of indomethacin and desipramine.
Journal of Hypertension 8 827–833.
Saruta T 1996 Mechanism of glucocorticoid-induced hypertension.
Hypertension Research 19 1–8.
Seckl JR 2004 Prenatal glucocorticoids and long-term programming.
European Journal of Endocrinology 151(Suppl 3) U49–U62.
Slotkin TA, Lappi SE, McCook EC, Tayyeb MI, Eylers JP & Seidler FJ 1992
Glucocorticoids and the development of neuronal function: effects of
prenatal dexamethasone exposure on central noradrenergic activity. Biology
of the Neonate 61 326–336.
Stein HM, Martinez A, Blount L, Oyama K & Padbury JF 1994 The effects of
corticosteroids and thyrotropin-releasing hormone on newborn adaptation
and sympathoadrenal mechanisms in preterm sheep. American Journal of
Obstetrics and Gynecology 171 17–24.
Sugden MC, Langdown ML, Munns MJ & Holness MJ 2001 Maternal
glucocorticoid treatment modulates placental leptin and leptin receptor
expression and materno–fetal leptin physiology during late pregnancy, and
elicits hypertension associated with hyperleptinaemia in the early-growth-
retarded adult offspring. European Journal of Endocrinology 145 529–539.
Tonkiss J, Trzcinska M, Galler JR, Ruiz-Opazo N & Herrera VL 1998 Prenatal
malnutrition-induced changes in blood pressure: dissociation of stress and
nonstress responses using radiotelemetry. Hypertension 32 108–114.
Torres A, Belser WW, III, Umeda PK & Tucker D 1997 Indicators of delayed
maturation of rat heart treated prenatally with dexamethasone. Pediatric
Research 42 139–144.
Tseng YT, Tucker MA, Kashiwai KT, Waschek JA & Padbury JF 1995
Regulation of beta 1-adrenoceptors by glucocorticoids and thyroid
hormones in fetal sheep. European Journal of Pharmacology 289 353–359.
Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, Wohlfart P,
Kleinert H, Lehr HA, Lemmer B & Forstermann U 1999 Down-regulation
of the expression of endothelial NO synthase is likely to contribute to
glucocorticoid-mediated hypertension. PNAS 96 13357–13362.
Weitz G, Deckert P, Heindl S, Struck J, Perras B & Dodt C 2003 Evidence for
lower sympathetic nerve activity in young adults with low birth weight.
Journal of Hypertension 21 943–950.
Welberg LA, Seckl JR & Holmes MC 2001 Prenatal glucocorticoid
programming of brain corticosteroid receptors and corticotrophin-releasing
hormone: possible implications for behaviour. Neuroscience 104 71–79.
Whitesall SE, Hoff JB, Vollmer AP & D’Alecy LG 2004 Comparison of
simultaneous measurement of mouse systolic arterial blood pressure by
radiotelemetry and tail-cuff methods. American Journal of Physiology 286
H2408–H2415.
Whitworth JA, Brown MA, Kelly JJ & Williamson PM 1995 Experimental
studies on cortisol-induced hypertension in humans. Steroids 9 395–480.
Woodall SM, Johnston BM, Breier BH & Gluckman PD 1996 Chronic
maternal undernutrition in the rat leads to delayed postnatal growth and
elevated blood pressure of offspring. Pediatric Research 40 438–443.
Woods LL 2006 Maternal glucocorticoids and prenatal programming of
hypertension. American Journal of Physiology 291 R1069–R1075.
Woods LL & Weeks DA 2005 Prenatal programming of adult blood pressure:
role of maternal corticosteroids. American Journal of Physiology R955–R962.
Received in ﬁnal form 4 October 2007
Accepted 1 November 2007
Made available online as an Accepted Preprint
1 November 2007
DO ’REGAN and others . Prenatal programming of hypertension 352
Journal of Endocrinology (2008) 196, 343–352 www.endocrinology-journals.org